Amyloidogenic regions in beta-strands II and III modulate the aggregation and toxicity of SOD1 in living cells.


Journal

Open biology
ISSN: 2046-2441
Titre abrégé: Open Biol
Pays: England
ID NLM: 101580419

Informations de publication

Date de publication:
Jun 2024
Historique:
medline: 5 6 2024
pubmed: 5 6 2024
entrez: 5 6 2024
Statut: ppublish

Résumé

Mutations in the protein superoxide dismutase-1 (SOD1) promote its misfolding and aggregation, ultimately causing familial forms of the debilitating neurodegenerative disease amyotrophic lateral sclerosis (ALS). Currently, over 220 (mostly missense) ALS-causing mutations in the SOD1 protein have been identified, indicating that common structural features are responsible for aggregation and toxicity. Using

Identifiants

pubmed: 38835240
doi: 10.1098/rsob.230418
doi:

Substances chimiques

Superoxide Dismutase-1 EC 1.15.1.1
SOD1 protein, human 0
Protein Aggregates 0
Proline 9DLQ4CIU6V
Amyloid 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

230418

Subventions

Organisme : R. Howard Webster Foundation
Organisme : CIHR
Organisme : Canadian Consortium for Neurodegeneration
Organisme : Brain Canada

Auteurs

Luke McAlary (L)

Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.
Department of Physics and Astronomy, University of British Columbia, Vancouver, BC, Canada.

Jeremy R Nan (JR)

Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.

Clay Shyu (C)

Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.

Mine Sher (M)

Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.

Steven S Plotkin (SS)

Department of Physics and Astronomy, University of British Columbia, Vancouver, BC, Canada.
Genome Sciences and Technology Program, University of British Columbia, Vancouver, BC, Canada.

Neil R Cashman (NR)

Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH